U.S. markets closed
  • S&P 500

    3,666.72
    -2.29 (-0.06%)
     
  • Dow 30

    29,969.52
    +85.73 (+0.29%)
     
  • Nasdaq

    12,377.18
    +27.82 (+0.23%)
     
  • Russell 2000

    1,848.70
    +10.67 (+0.58%)
     
  • Crude Oil

    45.88
    +0.24 (+0.53%)
     
  • Gold

    1,844.90
    +3.80 (+0.21%)
     
  • Silver

    24.20
    +0.07 (+0.28%)
     
  • EUR/USD

    1.2160
    +0.0010 (+0.09%)
     
  • 10-Yr Bond

    0.9200
    -0.0280 (-2.95%)
     
  • GBP/USD

    1.3461
    +0.0009 (+0.06%)
     
  • USD/JPY

    103.7720
    -0.0880 (-0.08%)
     
  • BTC-USD

    19,498.51
    +47.00 (+0.24%)
     
  • CMC Crypto 200

    383.57
    +9.16 (+2.45%)
     
  • FTSE 100

    6,490.27
    +26.88 (+0.42%)
     
  • Nikkei 225

    26,752.78
    -56.59 (-0.21%)
     

Recap: Universal Health Services Q3 Earnings

Benzinga Insights
·1 min read

Shares of Universal Health Services (NYSE:UHS) increased 2.44% in after-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share rose 44.72% over the past year to $2.88, which beat the estimate of $1.94.

Revenue of $2,912,541,000 rose by 3.21% year over year, which beat the estimate of $2,780,000,000.

Guidance

Earnings guidance hasn't been issued by the company for now.

View more earnings on UHS

Universal Health Services hasn't issued any revenue guidance for the time being.

Price Action

Company's 52-week high was at $148.27

52-week low: $65.20

Price action over last quarter: down 3.32%

Company Profile

Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two key segments: Acute Care Hospital Services and Behavioral Health Services. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers. Each segment contributes roughly half of the firm's overall revenue. Universal Health Services receives a significant portion of its net patient revenue from Medicare and Medicaid. The largest proportion of the firm's net patient revenue is paid by managed care organizations.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.